检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.
研究兴趣

论文共 44 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Dupilumab Reduces Severe Exacerbations and Improves Lung Function in Patients With Type 2 Asthma Irrespective of Asthma Duration
W. Busse, M. Kraft, C. Domingo Ribas, L. Rogers,I. de Mir, D.J. Maselli, X. Soler, C. Xia,N. Pandit-Abid, J.A. Jacob-Nara, H. Sacks,P.J. Rowe,
C34. BIOLOGIC THERAPY IN THE FIGHT AGAINST ASTHMA AND ALLERGIC INFLAMMATION (2024)
引用0浏览0引用
0
0
Effect of Dupilumab Treatment on Mucus Plugging and Mucus Volume in Type 2 Asthma: The Phase 4 VESTIGE Trial
C. Porsbjerg, E. Dunican,N.L. Lugogo, M. Castro, A. Papi, V. Backer,C.E. Brightling, A. Bourdin, J.C. Virchow, M. Zhang, X. Soler,P.J. Rowe,
A34. LATE BREAKING ABSTRACTS IN ASTHMA AND ALLERGIC INFLAMMATION (2024)
引用0浏览0引用
0
0
Treatment and Disease Burden Among Patients With Moderate or Severe COPD: Real World Study
J. Heble, A. Pawar, D. Cunoosamy, O. Ledanois,P.J. Rowe, J. Jacob-Nara
B32. BIOMARKERS AND TRANSLATIONAL STUDIES IN COPD AND CHRONIC AIRWAYS DISEASES (2024)
引用0浏览0引用
0
0
Improved Lung Function Is Associated With Better Asthma Control in Children With Moderate-to-Severe Type 2 Asthma: Voyage Study
L.B. Bacharier, S. Dell, I. De Mir-Messa, G. Piacentini, E. Hamelmann, J. Msihid, R. Gall, O. Ledanois, Z. Wang, W.W.-H. Cheng, H. Sacks, J.A. Jacob-Nara,
C34. BIOLOGIC THERAPY IN THE FIGHT AGAINST ASTHMA AND ALLERGIC INFLAMMATION (2024)
引用0浏览0引用
0
0
Effect of Dupilumab on Airway Oscillometry, Ventilation/Perfusion, and Mucus Plugging in Moderate-to-Severe Asthma: The Vestige Trial
G.R. Washko, B.J. Lipworth, D. Saralaya, M. Zhang, X. Soler, H. Sacks, Y. Deniz,P.J. Rowe,L. De Prado Gomez, J.A. Jacob-Nara
B14. LATE BREAKING ABSTRACTS: SCIENCE THAT WILL IMPACT CLINICAL CARE (2024)
引用0浏览0引用
0
0
Dupilumab Add-on to Medium-dose Inhaled Corticosteroid (ICS) Increases Odds of Asthma Control and Reduces FeNO Compared With Placebo Add-on to High-dose ICS
W. Busse, M. Castro,N.L. Lugogo, P.M. O’Byrne, L.B. Bacharier, C. Xia, M. Hardin, M. Soliman, H. Sacks, J.A. Jacob-Nara,P.J. Rowe, Y. Deniz
C34. BIOLOGIC THERAPY IN THE FIGHT AGAINST ASTHMA AND ALLERGIC INFLAMMATION (2024)
引用0浏览0引用
0
0
Évaluation de l’effet du dupilumab sur l’inflammation de type 2 des voies respiratoires et le bouchon de mucus chez les patients souffrant d’asthme modéré à sévère non contrôlé : l’essai VESTIGE
M. Castro, A. Papi, C. Porsbjerg,N.L. Lugogo, C.E. Brightling, F.J. González-Barcala, A. Bourdin, M. Ostrovskyy, M. Staevska, P.C. Chou, L. Duca, A.M. Pereira,
Revue Française d'Allergologie (2024)
引用0浏览0引用
0
0
Efficacy of dupilumab in patients with asthma stratified by a minimally important fractional exhaled nitric oxide reduction at week 2 of treatment
I. Pavord, M. Wechsler,W. W. Busse, C. Domingo, C. Xia, R. Gall,N. Pandit-Abid, J. A. Jacob-Nara, R. Amr,P. J. Rowe, Y. Deniz
ALLERGY (2023): 183-183
引用0浏览0引用
0
0
PCR200 Characteristics at Baseline of Patients with Asthma and Prior Systemic Corticosteroid Use Initiating Dupilumab Enrolled in the Real-World Study Rapid
N.L. Lugogo, E. Heffler, V. Plaza, O. Hilberg, C. Xia, S. Nash,N. Pandit-Abid, J.A. Jacob-Nara, H. Sacks,P.J. Rowe, Y. Deniz, M. Hardin,
Value in Healthno. 12 (2023): S487-S488
引用0浏览0引用
0
0
加载更多
作者统计
  • 合作者
  • 学生
  • 导师
暂无相似学者，你可以通过学者研究领域进行搜索筛选
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn